ANI Pharma (ANIP) Launches Nitazoxanide Tablets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
ANI Pharmaceuticals Announces the Launch of Nitazoxanide Tablets
March 19, 2025 6:50 AM EDTPRINCETON, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Nitazoxanide Tablets, 500 mg. ANIs Nitazoxanide Tablets are the generic version of the reference listed drug (RLD) Alinia®.
"The market launch of Nitazoxanide Tablets, another niche limited competition product, underscores our purpose of Serving Patients, Improving Lives, stated Nikhil Lalwani, President and Chief Executive Officer of ANI.
"We share ANIs commitment to providing affordable, high-quality medicines for the patients who depend on them and are... More



